Status:
COMPLETED
Automated Hovering to Improve Medication Adherence Among Myocardial Infarction Patients (Heartstrong)
Lead Sponsor:
University of Pennsylvania
Conditions:
Patients With Principal or Secondary Diagnosis Code of Intrntl Classification of Diseases, 9th Revision, (ICD-9-CM) 410 (Except When 5th Digit Was 2)
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this proposal is to test the implementation of an innovative approach to improving health and lowering cost for a high risk population of patients with acute myocardial infarction (AMI) im...
Detailed Description
The specific aims of this study are to: 1. Test the effectiveness of a state-of-the-art web-based portal with home-based wireless medication adherence devices and behavioral economic feedback mechani...
Eligibility Criteria
Inclusion
- Patients admitted to hospitals throughout New Jersey or at the University of Pennsylvania Health System who are discharged (or scheduled to be discharged) to their homes with a principal or secondary diagnosis code of International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) 410 (except when the fifth digit was 2)
- a length of stay of 1 to 180 days
- Aged 18 to 80 years
- Be discharged to home
- Prescribed at least 2 of these 4 medication categories (statin, aspirin, beta-blocker, anti-platelet)
Exclusion
- cannot give consent
- have a markedly shortened life expectancy (diagnosis of metastatic cancer, end-stage renal disease on dialysis, or dementia)
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
1509 Patients enrolled
Trial Details
Trial ID
NCT01800201
Start Date
March 1 2013
End Date
June 1 2017
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104